Holli Loomans-Kropp
Holli Loomans-Kropp is a prominent researcher from Ohio State University, known for leading a team that investigates the potential of metformin, a common diabetes medication, in complementing treatments for colon cancer, particularly those driven by the challenging KRAS gene mutations.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Turkey:
Holli Loomans-Kropp leads a research team investigating the effects of metformin on colon cancer cells.
8